During the past decade, Division of Cardiology, Pulmonary Disease and Vascular Medicine conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Division of Cardiology, Pulmonary Disease and Vascular Medicine" #1 collaborator was "Abiomed Inc." with 1 trials as a collaborator, "Philips Medical Systems" with 1 trials as a collaborator, "Profil Clinical Trials Coordination GmbH" with 1 trials as a collaborator, "SIRIO MEDICINE" with 1 trials as a collaborator and "University of Reading" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Division of Cardiology, Pulmonary Disease and Vascular Medicine" are "Cardiovascular Diseases" (4 trials), "Microcirculation" (3 trials), "FMD" (2 trials), "IMT" (2 trials) and "Intensive Care" (2 trials). Many other conditions were trialed in "Division of Cardiology, Pulmonary Disease and Vascular Medicine" in a lesser frequency.

Most popular intervention types in "Division of Cardiology, Pulmonary Disease and Vascular Medicine" are "Other" (9 trials), "Diagnostic Test" (4 trials), "Dietary Supplement" (4 trials), "Procedure" (4 trials) and "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "Flavanol rich intervention" (2 trials), "BAV" (1 trials), "BAV + TAVR" (1 trials), "Blood samples" (1 trials) and "Cardiac MRI and echocardiography, laboratory parameters" (1 trials). Other intervention names were less common.

The vast majority of trials in "Division of Cardiology, Pulmonary Disease and Vascular Medicine" are 25 trials for "All" genders, 4 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Division of Cardiology, Pulmonary Disease and Vascular Medicine". undefined are not yet recruiting, 7 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Division of Cardiology, Pulmonary Disease and Vascular Medicine, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Division of Cardiology, Pulmonary Disease and Vascular Medicine, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 10 trials that are defined as “Not Applicable".